Systemic lupus erythematosus syndrome induced by interferon therapy [4];Lupus eritematoso sistémico inducido por interferón pegilado

Medicina Clinica

Volumn 123, Issue 15, 2004, Pages 597-

  Martínez Alfaro, Elisa ^a   Mateos Rodríguez, Fernando ^a   Blanch Sancho, José Javier ^a   Tárraga Rodríguez, Ignacio ^a  

^a Unidad de Enfermedades Infecciosas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTHRALGIA; ARTHRITIS; ASTHENIA; AUTOIMMUNITY; CASE REPORT; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; FEVER; GENOTYPE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LABORATORY TEST; LETTER; LIVER BIOPSY; MEDICAL DECISION MAKING; NEUTROPENIA; PATIENT; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 19744382295     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13068010     Document Type: Letter

References (10)

1. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002;107:133-44.
2. Ronnblom LE, Alm GV, Obreg K. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol 1991;30:537-40.
3. Wilson LE, Widman D, Dikman SH, Gorevic PD. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002;32:163-73.
4. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf 1994;10:115-50.
5. Ronnblom LE, Alm GV, Obreg KE. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990;227:207-10.
6. Hory B, Blanc D, Saint-Hilier Y. Systemic lupus erythematosus-like syndrome induced by alpha-interferon therapy. Eur J Med 1992;1:379.
7. Sánchez Román J, Castillo Palma MJ, García Díaz E, Ferrer Ordínez JA. Lupus eritematoso sistémico inducido por tratamiento con interferón alfarrecombinante. Med Clin (Barc) 1994;105:198.
8. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K , Sakamoto M, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91.
9. Cush JJ, Goldings EA. Drug-induced lupus. Clinical spectrum pathogenesis. Am J Med Sci 1985;290:36-45.
10. a ed. mra ediciones, 2002; p. 457-65.